Uterine fibroids are common benign tumors in gynecology, and their size and number have different degrees of impact on patients’ quality of life and physical and mental health. The traditional treatment is surgical excision, but open surgery is highly invasive, with much intraoperative blood loss, leaving permanent scars in the abdomen, and can lead to intestinal adhesions or intestinal obstruction complications, adding new pain to the patient. More importantly, patients not only lose their precious uterus, but also enter menopause early, such as fat, sweating, irritability, coronary heart disease, osteoporosis, skin loss of luster, laxity, easy to appear spots and pigmentation, prone to vaginitis, vaginal dryness, decreased libido, seriously affecting the life of couples, individual severe cases can also appear depressive symptoms, become paranoid, affecting family harmony, and even suicidal tendencies, in order to To solve the above problems, they have to rely on long-term lifelong medication. Patients often delay treatment due to fear of surgery, causing unnecessary pain. The uterus is not only a normal reproductive and physiological organ of women, but also has a very important and indispensable endocrine function. Therefore, patients want to receive minimally invasive, effective and safe treatment based on preserving the uterus. Interventional treatment of uterine fibroids is a truly minimally invasive treatment. It is available to all patients with uterine fibroids that have been excluded from malignant changes. After the treatment, the patient’s symptoms disappear quickly, the fibroids are completely necrotic, and the postoperative recovery is quick, so that the patient does not have to undergo complicated and damaging surgical procedures. In this method, the patient does not have to undergo surgery, but only needs to make a very small incision in the inguinal area of the patient, and under the guidance of imaging equipment, a microscopic catheter is precisely introduced into the uterine artery along the femoral artery, and then an embolic agent is injected to close the vascular bed of the tumor, causing ischemia, necrosis and atrophy of the fibroid. Compared with surgical operation, it is less traumatic and can be used for normal activities 24 hours after surgery; fast recovery and can be discharged from hospital 3-5 days after surgery; good effect, generally the fibroids shrink about 35%-45% on average in 3 months after surgery, and shrink more than 90% in 12 months, or even disappear completely, and the period and menstrual volume start to return to normal in the 2nd-3rd months after surgery; less complications and almost no effect on women’s endocrine function. There are few complications, and there is almost no effect on the endocrine function of women, and pregnant women can have normal pregnancy and healthy babies after surgery.